Kresko RNAtech Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$200K
- Investors
-
14
Kresko RNAtech General Information
Description
Developer of bioactive RNA-based functional ingredients designed for human health, nutrition, and personal care applications. The company offers proprietary ingredients derived from food and plant sources using AI-powered RNA discovery, stabilization technologies, and biological validation, enabling brands and manufacturers to develop differentiated, science-backed products for sleep and relaxation, skin health, and other wellness applications.
Contact Information
Website
www.kreskornatech.comCorporate Office
- 12 North Cheyenne Avenue
- Tulsa, OK 74103
- United States
Corporate Office
- 12 North Cheyenne Avenue
- Tulsa, OK 74103
- United States
Kresko RNAtech Timeline
Kresko RNAtech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 18-Sep-2026 | $200K | In Progress | Startup | ||
| 12. Grant | 04-May-2026 | Completed | Startup | |||
| 11. Accelerator/Incubator | 01-Jan-2026 | Completed | Startup | |||
| 10. Accelerator/Incubator | 01-Jul-2025 | Completed | Startup | |||
| 9. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 8. Early Stage VC | 01-Oct-2023 | Completed | Startup | |||
| 7. Accelerator/Incubator | 25-May-2023 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup | |||
| 5. Early Stage VC | 06-Oct-2022 | $200K | $200K | Completed | Startup | |
| 4. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Kresko RNAtech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kresko RNAtech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kresko RNAtech Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| George Kaiser Family Foundation | Limited Partner | |||
| Space F | Accelerator/Incubator | |||
| Parallel18 | Accelerator/Incubator | |||
| Plug and Play | Accelerator/Incubator | |||
| IndieBio | Accelerator/Incubator |
Kresko RNAtech FAQs
-
When was Kresko RNAtech founded?
Kresko RNAtech was founded in 2021.
-
Where is Kresko RNAtech headquartered?
Kresko RNAtech is headquartered in Tulsa, OK.
-
What is the size of Kresko RNAtech?
Kresko RNAtech has 6 total employees.
-
What industry is Kresko RNAtech in?
Kresko RNAtech’s primary industry is Biotechnology.
-
Is Kresko RNAtech a private or public company?
Kresko RNAtech is a Private company.
-
What is the current valuation of Kresko RNAtech?
The current valuation of Kresko RNAtech is .
-
What is Kresko RNAtech’s current revenue?
The current revenue for Kresko RNAtech is .
-
How much funding has Kresko RNAtech raised over time?
Kresko RNAtech has raised $770K.
-
Who are Kresko RNAtech’s investors?
George Kaiser Family Foundation, Space F, Parallel18, Plug and Play, and IndieBio are 5 of 14 investors who have invested in Kresko RNAtech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
